Diabetes Control

Jardiance is a prescription medication that contains the active ingredient empagliflozin. It is primarily used to manage and control blood sugar levels in individuals with type 2 diabetes. Jardiance belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.

The primary mechanism of action of Jardiance is to lower blood sugar levels by blocking the reabsorption of glucose by the kidneys, allowing excess glucose to be excreted in the urine. This helps reduce elevated blood sugar levels in people with diabetes and can contribute to better glycemic control.

In addition to its glucose-lowering effects, Jardiance has been shown to provide cardiovascular benefits by reducing the risk of major cardiovascular events, including heart attacks and strokes, in some individuals with type 2 diabetes.

Jardiance is usually taken as an oral tablet, often once daily, and it is typically used in conjunction with lifestyle modifications, including diet and exercise. It should be used under the guidance of a healthcare provider, and potential side effects and interactions with other medications should be discussed with a healthcare professional before starting treatment.